666

ADVAGENE BIOPHARMA CO LTD

No trades
See on Supercharts
Market capitalization
‪1.19 B‬TWD
−1.45TWD
‪−92.11 M‬TWD
0.00TWD
Beta (1Y)
0.60

About ADVAGENE BIOPHARMA CO LTD


CEO
Yu Shen Hsu
Headquarters
Taipei
Founded
2006
ISIN
TW0006709009
FIGI
BBG00MMP4V35
Advagene Biopharma Co., Ltd. engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy. The company was founded on September 19, 2006 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6709 is 20.00 TWD — it has decreased by −0.25% in the past 24 hours. Watch ADVAGENE BIOPHARMA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ADVAGENE BIOPHARMA CO LTD stocks are traded under the ticker 6709.
6709 stock has fallen by −6.53% compared to the previous week, the month change is a −16.46% fall, over the last year ADVAGENE BIOPHARMA CO LTD has showed a −22.03% decrease.
6709 reached its all-time high on May 13, 2021 with the price of 97.40 TWD, and its all-time low was 14.15 TWD and was reached on Mar 24, 2020. View more price dynamics on 6709 chart.
See other stocks reaching their highest and lowest prices.
6709 stock is 2.55% volatile and has beta coefficient of 0.60. Track ADVAGENE BIOPHARMA CO LTD stock price on the chart and check out the list of the most volatile stocks — is ADVAGENE BIOPHARMA CO LTD there?
Today ADVAGENE BIOPHARMA CO LTD has the market capitalization of ‪1.19 B‬, it has decreased by −9.07% over the last week.
Yes, you can track ADVAGENE BIOPHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
6709 net income for the last half-year is ‪−31.41 M‬ TWD, while the previous report showed ‪−45.48 M‬ TWD of net income which accounts for 30.94% change. Track more ADVAGENE BIOPHARMA CO LTD financial stats to get the full picture.
No, 6709 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6709 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADVAGENE BIOPHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADVAGENE BIOPHARMA CO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADVAGENE BIOPHARMA CO LTD stock shows the sell signal. See more of ADVAGENE BIOPHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.